作者:George R. Pettit、Noeleen Melody、Jean-Charles Chapuis
DOI:10.1021/acs.jnatprod.7b00536
日期:2018.3.23
The medicinal potential of the plant pentacyclic triterpene betulin has generated long-term interest focused on various SAR research avenues. The present approach was based on producing further analogues (chimeras) arising from a studied modification of betulin bonded to the Dov-Val-Dil-Dap unit of the powerful anticancer drug dolastatin 10, which provided betulastatins 1 (7b), 2 (11b), 3 (16b), and
[EN] BETULASTATIN COMPOUNDS<br/>[FR] COMPOSÉS DE BÉTULASTATINE
申请人:PETTIT GEORGE R
公开号:WO2019094709A1
公开(公告)日:2019-05-16
The present disclosure relates to Betulastatin compounds, pharmaceutical compositions and kits comprising such compounds, and methods for using such compounds or pharmaceutical compositions.